Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (22598)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2015 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 2015; 21(6): 1956-1971 [PMID: 25684965 DOI: 10.3748/wjg.v21.i6.1956] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i6/1956.htm |
| Number | Citing Articles |
| 1 |
Johan Vessby, Maria Lampinen, Mikael Åberg, Fredrik Rorsman, Agneta Siegbahn, Alkwin Wanders, Marie Carlson. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis. Upsala Journal of Medical Sciences 2019; 124(4): 238 doi: 10.1080/03009734.2019.1689209
|
| 2 |
David Ellinghaus, Luke Jostins, Sarah L Spain, Adrian Cortes, Jörn Bethune, Buhm Han, Yu Rang Park, Soumya Raychaudhuri, Jennie G Pouget, Matthias Hübenthal, Trine Folseraas, Yunpeng Wang, Tonu Esko, Andres Metspalu, Harm-Jan Westra, Lude Franke, Tune H Pers, Rinse K Weersma, Valerie Collij, Mauro D'Amato, Jonas Halfvarson, Anders Boeck Jensen, Wolfgang Lieb, Franziska Degenhardt, Andreas J Forstner, Andrea Hofmann, Stefan Schreiber, Ulrich Mrowietz, Brian D Juran, Konstantinos N Lazaridis, Søren Brunak, Anders M Dale, Richard C Trembath, Stephan Weidinger, Michael Weichenthal, Eva Ellinghaus, James T Elder, Jonathan N W N Barker, Ole A Andreassen, Dermot P McGovern, Tom H Karlsen, Jeffrey C Barrett, Miles Parkes, Matthew A Brown, Andre Franke. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nature Genetics 2016; 48(5): 510 doi: 10.1038/ng.3528
|
| 3 |
Franziska Mathies, Niklas Steffens, Doerte Kleinschmidt, Friederike Stuhlmann, Francis J Huber, Urmi Roy, Thomas Meyer, Marc Luetgehetmann, Mareike von Petersdorff, Oliver Seiz, Johannes Herkel, Christoph Schramm, Richard A Flavell, Nicola Gagliani, Christian Krebs, Ulf Panzer, Zeinab Abdullah, Till Strowig, Tanja Bedke, Samuel Huber. Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells. The Journal of Immunology 2018; 201(12): 3558 doi: 10.4049/jimmunol.1800711
|
| 4 |
Ming-Hsi Wang, Omar Y Mousa, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly C Cushing, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Inflammatory Bowel Diseases 2020; 26(5): 774 doi: 10.1093/ibd/izz209
|
| 5 |
Christopher Chang, Atsushi Tanaka, Christopher Bowlus, M. Eric Gershwin. The use of biologics in the treatment of autoimmune liver disease. Expert Opinion on Investigational Drugs 2020; 29(4): 385 doi: 10.1080/13543784.2020.1733527
|
| 6 |
Christian Schineis. Chirurgie des unteren Gastrointestinaltrakts und Allgemeine Chirurgie. Springer Reference Medizin 2024; : 235 doi: 10.1007/978-3-662-63356-4_72
|
| 7 |
Shintaro Akiyama, Soma Fukuda, Joshua M Steinberg, Hideo Suzuki, Kiichiro Tsuchiya. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. World Journal of Gastroenterology 2022; 28(25): 2843-2853 doi: 10.3748/wjg.v28.i25.2843
|
| 8 |
Kwang Woo Kim, Hyoun Woo Kang. Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease. Intestinal Research 2023; 21(4): 413 doi: 10.5217/ir.2023.00133
|
| 9 |
Alicia R. Andrews, Juan Putra. Special Considerations in Pediatric Inflammatory Bowel Disease Pathology. Diagnostics 2025; 15(7): 831 doi: 10.3390/diagnostics15070831
|
| 10 |
Elisa Catanzaro, Enrico Gringeri, Nora Cazzagon, Annarosa Floreani, Umberto Cillo, Patrizia Burra, Martina Gambato. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. Journal of Personalized Medicine 2024; 14(3): 222 doi: 10.3390/jpm14030222
|
| 11 |
David Huynh, Denis Rubtsov, Myat Myat Khaing. Efficacy of Biologics in the Treatment of Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.56182
|
| 12 |
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework. American Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
|
| 13 |
Christopher Bowlus, David N. Assis, David Goldberg. Zakim and Boyer's Hepatology. 2018; : 626 doi: 10.1016/B978-0-323-37591-7.00043-4
|
| 14 |
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entity. Expert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
|
| 15 |
Michael F. McGee, Scott A. Strong. Inflammatory, infectious, and ischemic disorders of the pelvic pouch. Seminars in Colon and Rectal Surgery 2019; 30(1): 10 doi: 10.1053/j.scrs.2019.01.004
|
| 16 |
Tej I. Mehta, Simcha Weissman, Brian M. Fung, John Sotiriadis, Keith D. Lindor, James H. Tabibian. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta‐analysis. Liver International 2021; 41(10): 2418 doi: 10.1111/liv.15007
|
| 17 |
Pooya Jalali, Malihe Rezaee, Alireza Yaghoobi, Moein Piroozkhah, Mohammad Reza Zabihi, Shahram Aliyari, Zahra Salehi. Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis. Genomics & Informatics 2025; 23(1) doi: 10.1186/s44342-025-00045-4
|
| 18 |
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3): 761 doi: 10.1016/j.jhep.2022.05.011
|
| 19 |
Kate D. Williamson, Roger W. Chapman. Primary sclerosing cholangitis: a clinical update. British Medical Bulletin 2015; 114(1): 53 doi: 10.1093/bmb/ldv019
|
| 20 |
Magali Svrcek, Paula Borralho Nunes, Vincenzo Villanacci, Laurent Beaugerie, Gerhard Rogler, Gert De Hertogh, Monika Tripathi, Roger Feakins. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of Inflammation. Journal of Crohn's and Colitis 2018; doi: 10.1093/ecco-jcc/jjy132
|
| 21 |
Christian Schineis. Viszeral- und Allgemeinchirurgie. Springer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-61724-3_72-1
|
| 22 |
Kimberly Ortiz, Zeliha Cetin, Yiyue Sun, Zhiping Hu, Takeshi Kurihara, Edgar N. Tafaleng, Rodrigo M. Florentino, Alina Ostrowska, Alejandro Soto-Gutierrez, Lanuza A.P. Faccioli. Human Hepatocellular response in Cholestatic Liver Diseases. Organogenesis 2023; 19(1) doi: 10.1080/15476278.2023.2247576
|
| 23 |
Amera Elzubeir, Juliet High, Matthew Hammond, Lee Shepstone, Martin Pond, Martine Walmsley, Palak Trivedi, Emma Culver, Guruprasad Aithal, Jessica Dyson, Douglas Thorburn, Leo Alexandre, Simon Rushbrook. Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. BMJ Open Gastroenterology 2025; 12(1): e001596 doi: 10.1136/bmjgast-2024-001596
|
| 24 |
Fangming Wang, Junhui Xiao. The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-83085-0
|
| 25 |
Mike Van Der Have, Bas Oldenburg. Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?. Inflammatory Bowel Diseases 2020; 26(5): 780 doi: 10.1093/ibd/izz211
|
| 26 |
Brigid Pinnuck, Kate D. Lynch. Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy 2024; 25(13): 1835 doi: 10.1080/14656566.2024.2407022
|
| 27 |
Olga V. Usoltseva, Andrey N. Surkov, Alexander S. Potapov, Goar B. Movsisyan, Vladislav V. Chernikov. Association of autoimmune hepatobiliary pathology with inflammatory bowel diseases in children. Russian Pediatric Journal 2022; 25(2): 106 doi: 10.46563/1560-9561-2022-25-2-106-115
|
| 28 |
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
|
| 29 |
Tanja Bedke, Friederike Stumme, Miriam Tomczak, Babett Steglich, Rongrong Jia, Simon Bohmann, Agnes Wittek, Jan Kempski, Emilia Göke, Marius Böttcher, Dominik Reher, Anissa Franke, Maximilian Lennartz, Till Clauditz, Guido Sauter, Thorben Fründt, Sören Weidemann, Gisa Tiegs, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. Protective function of sclerosing cholangitis on IBD. Gut 2024; 73(8): 1292 doi: 10.1136/gutjnl-2023-330856
|
| 30 |
Eike Matthias Wacker, Florian Uellendahl-Werth, Saptarshi Bej, Olaf Wolkenhauer, Mette Vesterhus, Wolfgang Lieb, Andre Franke, Tom Hemming Karlsen, Trine Folseraas, David Ellinghaus. Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis. JHEP Reports 2024; 6(2): 100988 doi: 10.1016/j.jhepr.2023.100988
|
| 31 |
Mahmoud Mahfouz, Paul Martin, Andres F. Carrion. Hepatic Complications of Inflammatory Bowel Disease. Clinics in Liver Disease 2019; 23(2): 191 doi: 10.1016/j.cld.2018.12.003
|
| 32 |
Richard Kellermayer. Should all pediatric patients with type 1 autoimmune hepatitis be screened for inflammatory bowel disease?. JHEP Reports 2025; 7(3): 101291 doi: 10.1016/j.jhepr.2024.101291
|
| 33 |
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021; 2(2): 162 doi: 10.3390/transplantology2020016
|
| 34 |
Ming-Hsi Wang, Jessica J. Friton, Nancy Rebert, Kelly Monroe, Billy D. Nix, Claudio Fiocchi, Laura E. Raffals, Jonathan A. Leighton, Shabana F. Pasha, Michael F. Picco, Rodney D. Newberry, Jean-Paul Achkar, William A. Faubion. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis. Clinical and Translational Gastroenterology 2023; 14(9): e00615 doi: 10.14309/ctg.0000000000000615
|
| 35 |
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. Cancers 2023; 15(20): 4947 doi: 10.3390/cancers15204947
|
| 36 |
In Sub Han, Dong Hoon Baek, Seung Min Hong, Bong Eun Lee, Moon Won Lee, Gwang Ha Kim, Geun Am Song. Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04464-z
|
| 37 |
Remi Mahmoud, Shailja C. Shah, Joren R. ten Hove, Joana Torres, Erik Mooiweer, Daniel Castaneda, Jason Glass, Jordan Elman, Akash Kumar, Jordan Axelrad, Thomas Ullman, Jean-Frederic Colombel, Bas Oldenburg, Steven H. Itzkowitz. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases. Gastroenterology 2019; 156(5): 1333 doi: 10.1053/j.gastro.2018.11.067
|
| 38 |
Petronela Nicoleta Seritean Isac, Diana Popescu, Tudor Marcel Genes, Minerva Codruta Badescu, Ioana Irina Rezus, Nicoleta Dima, Ana Roxana Rusu Ganceanu, Elena Rezus, Ciprian Rezus. Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature Review. Journal of Interdisciplinary Medicine 2021; 6(3): 132 doi: 10.2478/jim-2021-0031
|
| 39 |
Burak Demir, Elgin Özkan, Seda Kaynak Şahap, Gizem Sütçü, Ceyda Tuna Kırsaçlıoğlu, Çiğdem Soydal, Ömer Suat Fitoz, Aydan Kansu Tanca, Emel Ünal. A Rare Case of “Periportal Cuffing” as an Incidental Finding on <sup>18</sup>F-FDG PET/CT. Molecular Imaging and Radionuclide Therapy 2023; 32(3): 252 doi: 10.4274/mirt.galenos.2023.53254
|
| 40 |
Ruben J. Colman, Jasbir Dhaliwal, Michael J. Rosen. Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.634739
|
| 41 |
Bettina M Buchholz, Panagis M Lykoudis, Reena Ravikumar, Joerg M Pollok, Giuseppe K Fusai. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. World Journal of Gastroenterology 2018; 24(28): 3171-3180 doi: 10.3748/wjg.v24.i28.3171
|
| 42 |
Brian M Fung, Keith D Lindor, James H Tabibian. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World Journal of Gastroenterology 2019; 25(6): 659-671 doi: 10.3748/wjg.v25.i6.659
|
| 43 |
Mohammad Egbaria, Amir Bieber, Abed Mahamid, Rawi Hazzan. Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03852-9
|
| 44 |
Dongyuan Zheng, Qinke Xu, Jin Wu, Zhouyue Gu, Jieya Chen, Yingchao Liu. Prevalence and bidirectional association between primary sclerosing cholangitis and Crohn's disease: A systematic review and meta-analysis. Gastroenterología y Hepatología 2025; : 502346 doi: 10.1016/j.gastrohep.2025.502346
|
| 45 |
Federica Fascì-Spurio, Polychronis Pavlidis, Ingvar Bjarnason. A new form of chronic inflammatory bowel disease associated with chronic liver disease. Scandinavian Journal of Gastroenterology 2016; 51(6): 644 doi: 10.3109/00365521.2015.1128141
|
| 46 |
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; doi: 10.1017/9781316823026
|
| 47 |
Tommaso D’Angelo, Silvio Mazziotti, Alfredo Blandino, Giuseppe Cicero. MR Enterography. 2022; : 73 doi: 10.1007/978-3-031-11930-9_6
|
| 48 |
Juliana Silva, Beatriz S. Brito, Isaac Neri de N. Silva, Viviane G. Nóbrega, Maria Carolina S. M. da Silva, Hemerson Dyego de N. Gomes, Flora Maria Fortes, Andrea M. Pimentel, Jaciane Mota, Neogélia Almeida, Valdiana C. Surlo, André Lyra, Raquel Rocha, Genoile O. Santana. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7604939
|
| 49 |
Kate D. Lynch, Roger W. Chapman, Satish Keshav, Aldo J. Montano-Loza, Andrew L. Mason, Andreas E. Kremer, Marcel Vetter, Manon de Krijger, Cyriel Y. Ponsioen, Palak Trivedi, Gideon Hirschfield, Christoph Schramm, Chung Heng Liu, Christopher L. Bowlus, Derek J. Estes, Daniel Pratt, Charlotte Hedin, Annika Bergquist, Annemarie C. de Vries, C. Janneke van der Woude, Lei Yu, David N. Assis, James Boyer, Henriette Ytting, Emina Hallibasic, Michael Trauner, Hanns-Ulrich Marschall, Luigi M. Daretti, Marco Marzioni, Kidist K. Yimam, Nicola Perin, Annarosa Floreani, Benedetta Terziroli Beretta-Piccoli, Jennifer K. Rogers, Cynthia Levy. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2020; 18(1): 179 doi: 10.1016/j.cgh.2019.05.013
|
| 50 |
David Ellinghaus. How genetic risk contributes to autoimmune liver disease. Seminars in Immunopathology 2022; 44(4): 397 doi: 10.1007/s00281-022-00950-8
|
| 51 |
Blair Fennimore, Emilie H. Regner, Mark E. Gerich. Primary Sclerosing Cholangitis. 2017; : 29 doi: 10.1007/978-3-319-40908-5_3
|
| 52 |
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
|
| 53 |
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, Mohammed Y Alghamdi, Abdullah S Alghamdi. Cholestatic liver disease. Saudi Journal of Gastroenterology 2021; 27(Suppl 1): S1 doi: 10.4103/sjg.sjg_112_21
|
| 54 |
Emily Read, Michael A. Curtis, Joana F. Neves. The role of oral bacteria in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2021; 18(10): 731 doi: 10.1038/s41575-021-00488-4
|
| 55 |
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Seminars in Liver Disease 2021; 41(03): 409 doi: 10.1055/s-0041-1730950
|
| 56 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígado. Gastroenterología y Hepatología 2019; 42(5): 316 doi: 10.1016/j.gastrohep.2019.02.004
|
| 57 |
Maysoon Gamaleldin, Luca Stocchi. Surgical Procedures on the Cirrhotic Patient. 2017; : 201 doi: 10.1007/978-3-319-52396-5_15
|
| 58 |
Nguyen Phung Vo, Anh Ho, Linh Ho. Nanocarriers Based Colon Targeting. 2025; : 423 doi: 10.1016/B978-0-443-24806-1.00017-0
|
| 59 |
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract. 2020; : 325 doi: 10.1017/9781316823026.022
|
| 60 |
Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmir Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitis. World Journal of Gastrointestinal Endoscopy 2024; 16(11): 607-616 doi: 10.4253/wjge.v16.i11.607
|
| 61 |
Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Elena A. Kulebina, Svetlana A. Simersina, Alexander S. Potapov, Maksim M. Lokhmatov. Primary sclerosing cholangitis in children with inflammatory bowel disease. Russian Pediatric Journal 2022; 24(6): 395 doi: 10.46563/1560-9561-2021-24-6-395-404
|
| 62 |
Lauren Van Der Kraak, Philippe Gros, Nicole Beauchemin. Colitis-associated colon cancer: Is it in your genes?. World Journal of Gastroenterology 2015; 21(41): 11688-11699 doi: 10.3748/wjg.v21.i41.11688
|
| 63 |
Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park. Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial. Clinical and Molecular Hepatology 2025; 31(1): 119 doi: 10.3350/cmh.2024.0629
|
| 64 |
Brian H. Horwich, Douglas T. Dieterich. Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis. Clinics in Liver Disease 2024; 28(1): 143 doi: 10.1016/j.cld.2023.07.006
|
| 65 |
Sreelakshmi Kotha, Ioannis Koumoutsos, Ben Warner, Eleni Theocharidou, Joel Mawdsley, Philip Berry. Setting up an integrated service for PSC-IBD patients: A quality improvement project. iLIVER 2024; 3(2): 100076 doi: 10.1016/j.iliver.2024.100076
|
| 66 |
Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India. Intestinal Research 2023; 21(4): 452 doi: 10.5217/ir.2022.00087
|
| 67 |
Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei. Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease. Intestinal Research 2022; 20(2): 224 doi: 10.5217/ir.2021.00042
|
| 68 |
Pilar López Serrano, Juan Turnes Vázquez. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunity. Revista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.7512/2020
|
| 69 |
Kevin De Muynck, Lindsey Devisscher. Targeting osteopontin to treat primary sclerosing cholangitis. Current Opinion in Gastroenterology 2024; 40(2): 77 doi: 10.1097/MOG.0000000000001001
|
| 70 |
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease. 2023; : 129 doi: 10.1007/978-3-031-14744-9_11
|
| 71 |
Amanda Ricciuto, Bettina E. Hansen, Brian Ngo, Marina Aloi, Thomas D. Walters, Peter C. Church, Abigail Mazurek, Maryam Khan, Nicholas Carman, Iram Siddiqui, Geoffrey C. Nguyen, Binita M. Kamath, Anne M. Griffiths. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth Impairment. Clinical Gastroenterology and Hepatology 2020; 18(7): 1509 doi: 10.1016/j.cgh.2019.08.048
|
| 72 |
Fatemeh Hadizadeh, Charlie W. Lees, Catherine Labbé, John D. Rioux, Miles Parkes, Alexandra Zhernakova, Andre Franke, Charlotte Hedin, Mauro D’Amato. Molecular Genetics of Inflammatory Bowel Disease. 2019; : 91 doi: 10.1007/978-3-030-28703-0_5
|
| 73 |
Britta Siegmund. Chronisch-entzündliche Darmerkrankungen. 2020; : 51 doi: 10.1007/978-3-662-59104-8_3
|
| 74 |
Keisuke Hata, Soichiro Ishihara, Hiroaki Nozawa, Kazushige Kawai, Tomomichi Kiyomatsu, Toshiaki Tanaka, Junko Kishikawa, Hiroyuki Anzai, Toshiaki Watanabe. Pouchitis after ileal pouch‐anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence. Digestive Endoscopy 2017; 29(1): 26 doi: 10.1111/den.12744
|
| 75 |
Roger M Feakins. Morson and Dawson's Gastrointestinal Pathology. 2024; : 709 doi: 10.1002/9781119423195.ch35
|
| 76 |
Kristel K. Leung, Wenbin Li, Bettina Hansen, Aliya Gulamhusein, Lauren Lapointe-Shaw, Abdel Aziz Shaheen, Amanda Ricciuto, Eric I. Benchimol, Jennifer A. Flemming, Gideon M. Hirschfield. Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence. JHEP Reports 2025; 7(3): 101272 doi: 10.1016/j.jhepr.2024.101272
|
| 77 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 78 |
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 2023; 55(7): 1380 doi: 10.1038/s12276-023-01042-9
|
| 79 |
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe. JHEP Reports 2022; 4(11): 100553 doi: 10.1016/j.jhepr.2022.100553
|
| 80 |
Dominika Suchecka, Joanna Harasym, Jacek Wilczak, Joanna Gromadzka-Ostrowska. Hepato- and gastro- protective activity of purified oat 1–3, 1–4-β- d -glucans of different molecular weight. International Journal of Biological Macromolecules 2016; 91: 1177 doi: 10.1016/j.ijbiomac.2016.06.062
|
| 81 |
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park. Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research 2023; 21(2): 252 doi: 10.5217/ir.2022.00092
|
| 82 |
Amr Sayed, David N. Assis, Marina G. Silveira, Yanhong Deng, Maria Ciarleglio, Jill K.J. Gaidos, Deborah D. Proctor, Badr Al-Bawardy. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2023; 35(3): 270 doi: 10.1097/MEG.0000000000002510
|
| 83 |
Sheena Mago, George Y. Wu. Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00036
|
| 84 |
Ruth Zhang, Gregory Y Lauwers, Won-Tak Choi. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(12): 1825 doi: 10.1093/ecco-jcc/jjac090
|
| 85 |
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
|
| 86 |
Way Seah Lee, Sivaramakrishnan Venkatesh Karthik, Ruey Terng Ng, Sik Yong Ong, Christina Ong, Fang K. Chiou, Shin Yee Wong, Seng Hock Quak, Marion Margaret Aw. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children. Pediatrics & Neonatology 2019; 60(4): 396 doi: 10.1016/j.pedneo.2018.09.007
|
| 87 |
Josiah D. McCain, David M. Chascsa, Keith D. Lindor. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients. Expert Opinion on Orphan Drugs 2021; 9(2): 53 doi: 10.1080/21678707.2021.1898370
|
| 88 |
Bence Kővári, Ágnes Báthori, Mark S. Friedman, Gregory Y. Lauwers. Histologic Diagnosis of Inflammatory Bowel Diseases. Advances in Anatomic Pathology 2022; 29(1): 48 doi: 10.1097/PAP.0000000000000325
|
| 89 |
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativa. Iatreia 2020; 33(3): 251 doi: 10.17533/udea.iatreia.57
|
| 90 |
Shaun R. Brown, Lisa C. Coviello. Extraintestinal Manifestations Associated with Inflammatory Bowel Disease. Surgical Clinics of North America 2015; 95(6): 1245 doi: 10.1016/j.suc.2015.08.002
|
| 91 |
Kate D. Lynch, Satish Keshav, Roger W. Chapman. The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Current Hepatology Reports 2019; 18(1): 115 doi: 10.1007/s11901-019-00456-2
|
| 92 |
Arash Motamed, Thang Tran, Mohamed H. Eloustaz. Obstetric Anesthesia and Uncommon Disorders. 2024; : 290 doi: 10.1017/9781009070256.019
|
| 93 |
Katie Ann Dunleavy, Priscila Santiago, Gerard Forde, W Scott Harmsen, Nicholas P McKenna, Nayantara Coelho-Prabhu, Sherief Shawki, Laura Raffals. Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2024; 30(11): 1935 doi: 10.1093/ibd/izad278
|
| 94 |
Sabrina Cardile, Tommaso Alterio, Manila Candusso, Andrea Pietrobattista, Daniela Liccardo, Maria Sole Basso, Bronislava Papadatou, Fiammetta Bracci, Daniela Knafelz, Giuliano Torre. Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 662 doi: 10.1080/00365521.2017.1298833
|
| 95 |
Meysam Olfatifar, Mohsen Rajabnia, Amir Sadeghi, Amirhassan Rabbani, Shabnam Shahrokh, Mohammad Amin Habibi, MehdiSure Pezeshgi Modarres, Mohammad Reza Zali, Hamidreza Houri, Maher Abdelraheim Titi. The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: An updated meta-analysis and modeling study. PLOS One 2025; 20(5): e0322479 doi: 10.1371/journal.pone.0322479
|
| 96 |
Malte Rühlemann, Timur Liwinski, Femke‐Anouska Heinsen, Corinna Bang, Roman Zenouzi, Martin Kummen, Louise Thingholm, Marie Tempel, Wolfgang Lieb, Tom Karlsen, Ansgar Lohse, Johannes Hov, Gerald Denk, Frank Lammert, Marcin Krawczyk, Christoph Schramm, Andre Franke. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Alimentary Pharmacology & Therapeutics 2019; 50(5): 580 doi: 10.1111/apt.15375
|
| 97 |
Henry Shiau, Faith D. Ihekweazu, Mansi Amin, Tatiana Fofanova, Tamir Miloh, Richard Kellermayer. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(4): 404 doi: 10.1097/MPG.0000000000001531
|
| 98 |
Souvik Sarkar, Christopher L. Bowlus. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2016; 20(1): 67 doi: 10.1016/j.cld.2015.08.005
|
| 99 |
Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa. Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I. BMJ Open Gastroenterology 2016; 3(1): e000122 doi: 10.1136/bmjgast-2016-000122
|
| 100 |
Jessica M. Ferrell. Circadian rhythms and inflammatory diseases of the liver and gut. Liver Research 2023; doi: 10.1016/j.livres.2023.08.004
|
| 101 |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
|
| 102 |
Matteo PEVIANI, Nora CAZZAGON, Martina GAMBATO, Luisa BERTIN, Fabiana ZINGONE, Edoardo V. SAVARINO, Brigida BARBERIO. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship. Minerva Gastroenterology 2025; 71(1) doi: 10.23736/S2724-5985.23.03605-7
|
| 103 |
Manon de Krijger, Manon E. Wildenberg, Wouter J. de Jonge, Cyriel Y. Ponsioen. Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis. Journal of Hepatology 2019; 71(3): 603 doi: 10.1016/j.jhep.2019.05.006
|
| 104 |
Istvan Fedor, Eva Zold, Zsolt Barta. Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel Diseases. Life 2023; 13(3): 652 doi: 10.3390/life13030652
|
| 105 |
Hiep Nguyen Canh, Kenichi Harada. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma. Medical Molecular Morphology 2016; 49(4): 189 doi: 10.1007/s00795-016-0143-6
|
| 106 |
Shailja C. Shah, Joren R. ten Hove, Daniel Castaneda, Carolina Palmela, Erik Mooiweer, Jean-Frédéric Colombel, Noam Harpaz, Thomas A. Ullman, Ad A. van Bodegraven, Jeroen M. Jansen, Nofel Mahmmod, Andrea E. van der Meulen-de Jong, Cyriel Y. Ponsioen, Christine J. van der Woude, Bas Oldenburg, Steven H. Itzkowitz, Joana Torres. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 2018; 16(7): 1106 doi: 10.1016/j.cgh.2018.01.023
|
| 107 |
Nan Wu, Fanyin Meng, Pietro Invernizzi, Francesca Bernuzzi, Julie Venter, Holly Standeford, Paolo Onori, Marco Marzioni, Domenico Alvaro, Antonio Franchitto, Eugenio Gaudio, Shannon Glaser, Gianfranco Alpini. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in mice. Hepatology 2016; 64(3): 865 doi: 10.1002/hep.28622
|
| 108 |
Morten L Halling, Jens Kjeldsen, Torben Knudsen, Jan Nielsen, Lars Koch Hansen. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World Journal of Gastroenterology 2017; 23(33): 6137-6146 doi: 10.3748/wjg.v23.i33.6137
|
| 109 |
Alexander J. Kovalic, Herbert L. Bonkovsky. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 9 doi: 10.1007/978-3-030-33628-8_2
|
| 110 |
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology 2021; 161(6): 1865 doi: 10.1053/j.gastro.2021.08.032
|
| 111 |
Girak Kim, Zuojia Chen, Jian Li, Jialie Luo, Felipe Castro-Martinez, Jan Wisniewski, Kairong Cui, Yan Wang, Jialei Sun, Xiaobai Ren, Susan E. Crawford, S. Patricia Becerra, Jimin Zhu, Taotao Liu, Sui Wang, Keji Zhao, Chuan Wu. Gut-liver axis calibrates intestinal stem cell fitness. Cell 2024; 187(4): 914 doi: 10.1016/j.cell.2024.01.001
|
| 112 |
Federica Del Chierico, Sabrina Cardile, Valerio Baldelli, Tommaso Alterio, Sofia Reddel, Matteo Bramuzzo, Daniela Knafelz, Sara Lega, Fiammetta Bracci, Giuliano Torre, Giuseppe Maggiore, Lorenza Putignani. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. Inflammatory Bowel Diseases 2024; 30(4): 529 doi: 10.1093/ibd/izad203
|
| 113 |
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. International Journal of Molecular Sciences 2021; 22(13): 6975 doi: 10.3390/ijms22136975
|
| 114 |
Sabina Wiecek, Alicja Wojtyniak, Barbara Pindur, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Urszula Grzybowska-Chlebowczyk. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population—Single Center Study. Medicina 2021; 57(7): 663 doi: 10.3390/medicina57070663
|
| 115 |
Felix Solberg, Bodil Ohlsson. Microscopic colitis and its associations with complications observed in classic inflammatory bowel disease: a systematic review. Scandinavian Journal of Gastroenterology 2020; 55(3): 312 doi: 10.1080/00365521.2020.1739325
|
| 116 |
Sun-Gou Ji, Brian D Juran, Sören Mucha, Trine Folseraas, Luke Jostins, Espen Melum, Natsuhiko Kumasaka, Elizabeth J Atkinson, Erik M Schlicht, Jimmy Z Liu, Tejas Shah, Javier Gutierrez-Achury, Kirsten M Boberg, Annika Bergquist, Severine Vermeire, Bertus Eksteen, Peter R Durie, Martti Farkkila, Tobias Müller, Christoph Schramm, Martina Sterneck, Tobias J Weismüller, Daniel N Gotthardt, David Ellinghaus, Felix Braun, Andreas Teufel, Mattias Laudes, Wolfgang Lieb, Gunnar Jacobs, Ulrich Beuers, Rinse K Weersma, Cisca Wijmenga, Hanns-Ulrich Marschall, Piotr Milkiewicz, Albert Pares, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H Ouwehand, David J Roberts, John Danesh, Annarosa Floreani, Aliya F Gulamhusein, John E Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L Bowlus, Velimir A Luketic, Joseph A Odin, Kapil B Chopra, Kris V Kowdley, Naga Chalasani, Michael P Manns, Brijesh Srivastava, George Mells, Richard N Sandford, Graeme Alexander, Daniel J Gaffney, Roger W Chapman, Gideon M Hirschfield, Mariza de Andrade, Simon M Rushbrook, Andre Franke, Tom H Karlsen, Konstantinos N Lazaridis, Carl A Anderson. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. Nature Genetics 2017; 49(2): 269 doi: 10.1038/ng.3745
|
| 117 |
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. World Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
|
| 118 |
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018). Terapevticheskii arkhiv 2019; 91(2): 9 doi: 10.26442/00403660.2019.02.000075
|
| 119 |
Sabina Wiecek. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy. 2022; doi: 10.5772/intechopen.102080
|
| 120 |
Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy
in patients with primary sclerosing cholangitis and IBD. Endoscopy International Open 2024; 12(11): E1285 doi: 10.1055/a-2437-8102
|
| 121 |
Mindy C Ward, Blake Studer, Ian Nora, Nathan Seepaulsing, Charles Loewe. Primary Sclerosing Cholangitis in Crohn’s Disease: An Atypical Complication. Cureus 2021; doi: 10.7759/cureus.14964
|
| 122 |
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation. Gastroenterología y Hepatología (English Edition) 2019; 42(5): 316 doi: 10.1016/j.gastre.2019.02.030
|
| 123 |
Taku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, Haruhiko Ogata, Akira Andoh, Toshimitsu Araki, Ryota Hokari, Hideki Iijima, Hiroki Ikeuchi, Yoh Ishiguro, Shingo Kato, Reiko Kunisaki, Takayuki Matsumoto, Satoshi Motoya, Masakazu Nagahori, Shiro Nakamura, Hiroshi Nakase, Tomoyuki Tsujikawa, Makoto Sasaki, Kaoru Yokoyama, Naoki Yoshimura, Kenji Watanabe, Miiko Katafuchi, Mamoru Watanabe, Toshifumi Hibi. Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries. Intestinal Research 2018; 16(2): 168 doi: 10.5217/ir.2018.16.2.168
|
| 124 |
Sabina Wiecek. Hepatitis A and Other Associated Hepatobiliary Diseases. 2020; doi: 10.5772/intechopen.90714
|
| 125 |
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1): 129 doi: 10.1016/j.cld.2023.07.005
|
| 126 |
Lídia Roque Ramos, Christopher J. DiMaio, David B. Sachar, Ashish Atreja, Jean-Frédéric Colombel, Joana Torres. Autoimmune pancreatitis and inflammatory bowel disease: Case series and review of the literature. Digestive and Liver Disease 2016; 48(8): 893 doi: 10.1016/j.dld.2016.05.008
|
| 127 |
Friederike Stumme, Niklas Steffens, Babett Steglich, Franziska Mathies, Mikolaj Nawrocki, Morsal Sabihi, Shiwa Soukou-Wargalla, Emilia Göke, Jan Kempski, Thorben Fründt, Sören Weidemann, Christoph Schramm, Nicola Gagliani, Samuel Huber, Tanja Bedke. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1307297
|
| 128 |
Trevor J Laborda, M Kyle Jensen, Marianne Kavan, Mark Deneau. Treatment of primary sclerosing cholangitis in children. World Journal of Hepatology 2019; 11(1): 19-36 doi: 10.4254/wjh.v11.i1.19
|
| 129 |
Andrew J. Muir. What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?. Clinical Gastroenterology and Hepatology 2020; 18(10): 2173 doi: 10.1016/j.cgh.2020.03.053
|
| 130 |
Rosario Fornaro, Michela Caratto, Elisa Caratto, Giuseppe Caristo, Francesco Fornaro, Davide Giovinazzo, Camilla Sticchi, Marco Casaccia, Enzo Andorno. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program. Clinical Colorectal Cancer 2016; 15(3): 204 doi: 10.1016/j.clcc.2016.02.002
|
| 131 |
Fen Ming Zhang, Cheng Fu Xu, Guo Dong Shan, Hong Tan Chen, Guo Qiang Xu. Is gallstone disease associated with inflammatory bowel diseases? A meta‐analysis. Journal of Digestive Diseases 2015; 16(11): 634 doi: 10.1111/1751-2980.12286
|
| 132 |
Haim Leibovitzh, Shadi Nayeri, Krzysztof Borowski, Cristian Hernandez-Rocha, Sun-Ho Lee, Williams Turpin, Joanne M Stempak, Iqbaljit Sandhu, Raquel Milgrom, Michelle I Smith, Kenneth Croitoru, Gideon M Hirschfield, Aliya Gulamhusein, Mark S Silverberg. Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile. Journal of Crohn's and Colitis 2024; 18(12): 1957 doi: 10.1093/ecco-jcc/jjae096
|
| 133 |
Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2023; 13(2): 350 doi: 10.1016/j.jceh.2022.07.002
|
| 134 |
MT Ko, A Hammodi. How to approach jaundice in the MRCP PACES exam. British Journal of Hospital Medicine 2023; 84(2): 1 doi: 10.12968/hmed.2022.0438
|
| 135 |
Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matías A. Ávila, Yulia A. Nevzorova, Francisco Javier Cubero. Fibrotic Events in the Progression of Cholestatic Liver Disease. Cells 2021; 10(5): 1107 doi: 10.3390/cells10051107
|
| 136 |
Jessica Colin Escobar, Maria Navarez Pereyra, Mohammad Ali Abbass. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Surgical Clinics of North America 2025; 105(2): 375 doi: 10.1016/j.suc.2024.11.001
|
| 137 |
Serena Bertoni, Ariella Machness, Mattia Tiboni, Raquel Bártolo, Hélder A. Santos. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting. Biopolymers 2020; 111(1) doi: 10.1002/bip.23336
|
| 138 |
Craig Lammert, Veronica M. Loy, Kiyoko Oshima, Samer Gawrieh. Management of Difficult Cases of Autoimmune Hepatitis. Current Gastroenterology Reports 2016; 18(2) doi: 10.1007/s11894-015-0484-7
|
| 139 |
|
| 140 |
Nahla Azzam, Yazed AlRuthia, Othman Alharbi, Abdulrahman Aljebreen, Majid Almadi, Edward V. Loftus. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease. Hepatology International 2020; 14(6): 1114 doi: 10.1007/s12072-020-10110-5
|
| 141 |
Wassel Sannaa, Mazen Almasry, Mustafa Peedikayil, Alyssa A. Grimshaw, Mashary Attamimi, Abdulelah AlMutairdi, Badr Al-Bawardy. Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848241312766
|
| 142 |
Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease. BMJ Open Gastroenterology 2023; 10(1): e001141 doi: 10.1136/bmjgast-2023-001141
|
| 143 |
Chuan Liu, Rong Yu, Jixiang Zhang, Shuchun Wei, Fumin Xue, Yingyun Guo, Pengzhan He, Lining Shang, Weiguo Dong. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.972079
|
| 144 |
Luca Maroni, Elisabetta Ninfole, Claudio Pinto, Antonio Benedetti, Marco Marzioni. Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology. Cells 2020; 9(3): 736 doi: 10.3390/cells9030736
|
| 145 |
Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis. Vnitřní lékařství 2018; 64(6): 659 doi: 10.36290/vnl.2018.090
|
| 146 |
|
| 147 |
João Sabino, Joren tenHove, Joana Torres. Biomarkers in Inflammatory Bowel Diseases. 2019; : 191 doi: 10.1007/978-3-030-11446-6_16
|
| 148 |
Gordon W Moran, Morris Gordon, Vassiliki Sinopolou, Shellie J Radford, Ana-Maria Darie, Sudheer Kumar Vuyyuru, Laith Alrubaiy, Naila Arebi, Jonathan Blackwell, Thomas D Butler, Thean Chew, Michael Colwill, Rachel Cooney, Gabriele De Marco, Said Din, Shahida Din, Roger Feakins, Marco Gasparetto, Hannah Gordon, Richard Hansen, Klaartje B Kok, Christopher Andrew Lamb, Jimmy Limdi, Eleanor Liu, Maurice B Loughrey, Dennis McGonagle, Kamal Patel, Polychronis Pavlidis, Christian Selinger, Matthew Shale, Philip J Smith, Sreedhar Subramanian, Stuart A Taylor, Gloria Shwe Zin Tun, Ajay Mark Verma, Newton A C S Wong. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut 2025; 74(Suppl 2): s1 doi: 10.1136/gutjnl-2024-334395
|
| 149 |
Lina Lindström, Kristin K. Jørgensen, Kirsten M. Boberg, Maria Castedal, Allan Rasmussen, Andreas Arendtsen Rostved, Helena Isoniemi, Matteo Bottai, Annika Bergquist. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scandinavian Journal of Gastroenterology 2018; 53(3): 297 doi: 10.1080/00365521.2017.1421705
|
| 150 |
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021; 161(6): 1764 doi: 10.1053/j.gastro.2021.07.046
|
| 151 |
Patrick F. van Rheenen, Kaija‐Leena Kolho, Richard K. Russell, Marina Aloi, Annamaria Deganello, Séamus Hussey, Norman Junge, Jan De Laffolie, Mark R. Deneau, Emer Fitzpatrick, Anne M. Griffiths, Iva Hojsak, Emanuele Nicastro, Andreia Nita, Mikko Pakarinen, Amanda Ricciuto, Lissy de Ridder, Aurelio Sonzogni, Andrea Tenca, Marianne Samyn, Giuseppe Indolfi. Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto group. Journal of Pediatric Gastroenterology and Nutrition 2025; 80(2): 374 doi: 10.1002/jpn3.12378
|
| 152 |
Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?. Journal of Hepatology 2024; 80(1): 155 doi: 10.1016/j.jhep.2023.09.031
|
| 153 |
|
| 154 |
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse, Mark Hudson. Primary sclerosing cholangitis. The Lancet 2018; 391(10139): 2547 doi: 10.1016/S0140-6736(18)30300-3
|
| 155 |
Atsushi Tanaka, Joachim C. Mertens. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?. Inflammatory Intestinal Diseases 2016; 1(1): 9 doi: 10.1159/000445259
|
| 156 |
Bence Kővári, Rish K. Pai. Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls. Advances in Anatomic Pathology 2022; 29(1): 2 doi: 10.1097/PAP.0000000000000311
|
| 157 |
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023; 13(3): 378 doi: 10.3390/metabo13030378
|
| 158 |
Xiaoyong Xue, Jianzhi Wu, Mingning Ding, Feng Gao, Fei Zhou, Bing Xu, Mingjun Lu, Jun Li, Xiaojiaoyang Li. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00524-0
|
| 159 |
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
|
| 160 |
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBD. Current Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
|
| 161 |
Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020; : 35 doi: 10.1016/B978-0-12-814811-2.00004-9
|
| 162 |
Rinse K. Weersma, Keith D. Lindor. Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?. Gastroenterology 2016; 151(4): 590 doi: 10.1053/j.gastro.2016.08.046
|
| 163 |
Kai Markus Schneider, Lena Susanna Candels, Johannes R. Hov, Maiju Myllys, Reham Hassan, Carolin Victoria Schneider, Annika Wahlström, Antje Mohs, Sebastian Zühlke, Lijun Liao, Carsten Elfers, Konrad Kilic, Marcus Henricsson, Antonio Molinaro, Maximilian Hatting, Ayham Zaza, Dirk Drasdo, Mick Frissen, A. Sloan Devlin, Eric J. C. Gálvez, Till Strowig, Tom H. Karlsen, Jan G. Hengstler, Hanns-Ulrich Marschall, Ahmed Ghallab, Christian Trautwein. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling. Nature Metabolism 2021; 3(9): 1228 doi: 10.1038/s42255-021-00452-1
|
| 164 |
Ruth Zhang, Dongliang Wang, Gregory Y. Lauwers, Won-Tak Choi. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. American Journal of Surgical Pathology 2024; 48(9): 1154 doi: 10.1097/PAS.0000000000002255
|
| 165 |
Noa Krugliak Cleveland, David T. Rubin, John Hart, Christopher R. Weber, Katherine Meckel, Anthony L. Tran, Arthur S. Aelvoet, Isabella Pan, Alex Gonsalves, John Nick Gaetano, Kelli M. Williams, Kristen Wroblewski, Bana Jabri, Joel Pekow. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon. Clinical Gastroenterology and Hepatology 2018; 16(1): 68 doi: 10.1016/j.cgh.2017.07.023
|
| 166 |
Igor G. Bakulin, Svetlana A. Burlakova, Ekaterina V. Skazyvaeva, Maria I. Skalinskaya. Registry of patients with autoimmune liver diseases in St. Petersburg: clinical and epidemiological data. HERALD of North-Western State Medical University named after I.I. Mechnikov 2024; 16(2): 61 doi: 10.17816/mechnikov627505
|
| 167 |
S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Zeitschrift für Gastroenterologie 2025; 63(06): 604 doi: 10.1055/a-2558-5204
|